ArticleAesthetic plastic surgery2026
Percutaneous Aponeurotomy Combined with Autologous Fat Grafting for Early Dupuytren's Disease.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPercutaneous needle aponeurotomy (PNA) is a well-established minimally invasive technique for treating early-stage Dupuytren's disease; however, recurrence remains a concern. Recent studies have suggested that autologous fat grafting may have regenerative and antifibrotic effects, potentially improving clinical outcomes when combined with minimally invasive techniques.
methodsIn this current study, 57 patients with Tubiana stage 1-3 Dupuytren's disease were treated with PNA combined with autologous fat grafting between 2022 and 2024. Fat was harvested from the abdomen and processed via the cotton gauze rolling technique. Joint contractures were evaluated preoperatively and at 1 and 12 months postoperatively. Postoperative recovery time, complication rates, and recurrence were also analyzed.
resultsSignificant improvements were observed in both MCP and PIP joint contractures at 1 and 12 months (p < 0.001). The mean follow-up was 17.4 ± 3.4 months. No clinical recurrences were noted. Only 7% of patients experienced minor, self-limiting complications. Most patients resumed daily activities within one week postoperatively.
conclusionsPNA combined with autologous fat grafting offers a safe, effective, and biologically favorable approach for managing early-stage Dupuytren's disease. The technique promotes rapid recovery, minimizes complications, and may reduce recurrence through adipose tissue's regenerative and antifibrotic effects. This combined strategy represents a promising minimally invasive alternative to traditional open surgery. The addition of fat grafting provided improved tissue pliability, reduced postoperative pain, and enhanced healing. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41973231What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.